In the hushed halls of justice, whispers of misconduct are growing louder. Last week, allegations surfaced that top lawyers within the Trump administration’s Justice Department engaged in a pattern of alleged misrepresentations, prompting calls for Rule 11 sanctions from plaintiffs involved in a separate case concerning Mar-a-Lago.
This isn’t an isolated incident; it’s a developing narrative. Over a year ago, Deputy Assistant Attorney General Drew Ensign reportedly made a false statement directly to Chief Judge James Boasberg’s face concerning flights to CECOT in El Salvador. Since Acting AG Todd Blanche assumed leadership, the frequency of such alleged falsehoods appears to be on the rise.
Just in the past fortnight, accusations have mounted: Blanche was reportedly caught misrepresenting the Southern Poverty Law Center’s prior cooperation with law enforcement in a “fraud” case against the organization. Concurrently, a federal judge in Rhode Island initiated a misconduct investigation into the chief of the Civil Division at the US Attorney’s Office, Roger Bolan, citing a lack of candor toward the court.
A Strategic Dodge to Get a Favorable Judge?
Now, the Civil Division at Main Justice is allegedly misrepresenting both facts and law in a bid to access the sensitive medical privacy of thousands of transgender youth. This gambit has ignited a cross-country legal conflict already playing out in three separate jurisdictions.
The saga began in July 2025 when the Enforcement and Affirmative Litigation Branch (EALB) served administrative subpoenas on more than twenty hospitals and clinics nationwide. The demand? Patient records for any minor prescribed puberty blockers or hormone therapy for gender-affirming care. The stated justification: investigating mislabeled drugs under the Food, Drug, and Cosmetic Act (FDCA). Yet, court after court balked, quashing these subpoenas with findings of being overly broad, legally deficient, or issued in bad faith—essentially, a policy pursuit masquerading as a criminal investigation.
Negotiations with the DOJ for Rhode Island Hospital (RIH), affiliated with Brown University Health, initially seemed promising. Lawyers from the EALB reportedly indicated they didn’t believe RIH had engaged in wrongdoing and agreed to flexibility on an August 7 deadline. RIH submitted proposed search terms on February 4, 2026, only to receive a late response on April 28—an email proposing a “conference this week regarding status.” Instead of a conference, the DOJ filed a petition to enforce the subpoena in Fort Worth, Texas.
Texas, over 1,700 miles from a hospital in Rhode Island, is an undeniably inconvenient and questionable venue for such an enforcement action. The rationale? Avoid a likely quashing of the subpoena by courts in Rhode Island or the District of Columbia, where EALB is based and where RIH was directed to send records. So, the DOJ allegedly found a jurisdiction where it could stack the deck.
By claiming the investigation was being conducted in the Northern District of Texas, they filed in Fort Worth. This move was a calculated gambit to land before either Judge Reed O’Connor or Judge Mark Pittman—two conservative judges known for their alignment with right-wing litigants. Without even waiting for RIH’s response, Judge O’Connor reportedly signed the DOJ’s proposed order verbatim, giving the hospital a mere 14 days to surrender sensitive patient records or face contempt charges.
The ‘Three Court Circus’ Unfolds
This Texas ruling quickly escalated into a multi-state legal imbroglio. The Child Advocate for the State of Rhode Island, tasked with protecting the interests of children in foster care, filed suit in the District of Rhode Island to block the subpoena. RIH is seeking to intervene in this case.
Meanwhile, in Texas, RIH has appealed Judge O’Connor’s order to the Fifth Circuit on due process grounds and requested an emergency stay. They also petitioned Judge O’Connor himself to stay his March 14 deadline pending the outcome of the appeal.
The DOJ’s narrative consistency across these different judicial arenas is starting to fray. They have now asserted to multiple courts that this investigation is, in fact, being conducted in Texas. This stands in stark contrast to the reality: the subpoena originated from DC, demanded production to EALB’s DC office, every DOJ attorney involved works in DC, and RIH has no connection to Texas whatsoever. The crux of the matter now rests on an ex parte declaration—filed under seal and thus not shared with RIH—which allegedly contains the government’s justification for its venue choice.
“Court after court quashed them, characterizing the subpoenas as overbroad, legally deficient, or issued in bad faith to accomplish a policy goal rather than to investigate actual crimes.”
The legal strategy here, if proven, is bold, bordering on audacious. It suggests a willingness to bend procedural rules to achieve a desired policy outcome, particularly concerning a sensitive area of medical care that has become a political flashpoint. This isn’t just about one subpoena; it’s a signal about the DOJ’s approach to enforcement and its willingness to pursue policy goals through aggressive, potentially manipulative, legal means.
This tactic of choosing a forum specifically for a favorable bench—what’s known as ‘forum shopping’—is hardly new in legal circles. However, applying it to administrative subpoenas seeking highly sensitive personal health information, particularly regarding a vulnerable population, raises significant ethical and legal questions. It hints at a broader pattern within the DOJ where ideological objectives may be eclipsing rigorous legal process.
What’s particularly concerning is the alleged use of ex parte declarations. These are submissions made to the court without the opposing party present or notified. While sometimes permissible in specific circumstances (like protecting trade secrets or ongoing investigations), using them to justify a venue choice that appears designed to bypass judicial scrutiny in a more neutral forum is a red flag. It suggests an attempt to shield the reasoning behind the venue selection from public and judicial challenge.
The convergence of legal AI and these types of enforcement actions warrants close observation. While this particular case doesn’t directly involve AI tools being used by the DOJ for this specific subpoena, the underlying data being sought—patient records—is precisely the kind of sensitive information that could be subject to AI analysis in other contexts. The implications for privacy and the potential for misuse, even if not AI-driven at this stage, are substantial.
The Legal AI Beat’s Take: This isn’t just about a subpoena; it’s about due process and the integrity of the legal system. Accusations of forum shopping, particularly when coupled with alleged falsehoods and the pursuit of sensitive patient data under questionable pretenses, demand rigorous judicial review. The DOJ’s strategy here appears less about enforcing the Food, Drug, and Cosmetic Act and more about pursuing a political agenda through legal means. The courts will — and should — scrutinize this tactic intensely.
🧬 Related Insights
- Read more: USPTO PTAB Clash: Pharma Calls BS on Patent Thicket Hysteria
- Read more: Meta Rips Away Instagram’s Encryption Shield – Privacy’s Dark Day
Frequently Asked Questions
What is ‘forum shopping’ in the legal context? Forum shopping refers to the practice of litigants attempting to get their case heard in a particular court or jurisdiction that they believe will be most favorable to their cause, often due to favorable laws, judges, or procedures.
Are administrative subpoenas always lawful? No. Administrative subpoenas must be issued for a legitimate purpose related to an authorized investigation, be relevant to that purpose, and not be overly broad or unduly burdensome. Courts can quash them if these conditions aren’t met.
What are Rule 11 sanctions? Rule 11 of the Federal Rules of Civil Procedure allows courts to impose sanctions on attorneys or parties who file frivolous lawsuits, make false statements to the court, or otherwise abuse the judicial process. This can include monetary penalties or other disciplinary actions.
